Comparative Study Between CT Arthrography and MRI Arthrography in Detection of Intra-articular Hip Pathology

September 20, 2021 updated by: Nafisa Desouky Mohamed Hussein, Assiut University
The aim of this work is to compare the role of CT hip arthrography to MR arthrography in the detection of intra-articular hip pathology.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

The hip joint is a ball-and-socket synovial joint designed to allow multi-axial motion while transferring loads between the upper and lower body. The acetabular rim is lined by fibrocartilage (labrum), which adds depth and stability to the femoro-acetabular joint. The articular surfaces are covered by hyaline cartilage that dissipates shear and compressive forces during load bearing and hip motion.

Various anatomical factors make the investigation of suspected intra-articular hip pathology challenging. Lesions of the labrum, cartilaginous lesions, femoro-acetabular impingement (FAI), and intra-articular foreign bodies are the most common intra-articular pathology , others causes of intra-articular hip pain include ligamentum teres rupture, degenerative changes, arthritis (inflammatory, infectious, etc.), and synovial proliferative disorders.

The labrum is a fibrocartilaginous triangular-shaped incomplete ring that surrounds the bony acetabulum. The labrum increases the depth of the acetabulum, thereby assisting hip stability and distributing hip load. It also seals the hip joint, helping to maintain synovial fluid within the central compartment and becoming a mechanical stabilizer. The articular cartilage of the acetabulum has a horseshoe shaped appearance with an opening at the acetabular notch, is not as thick as in other joints such as the knee. Hip cartilage in adults has been estimated to be between 1 and 2 mm in thickness. Thus, plain MRI and CT have limited value in assessing labral and articular cartilage disorders. Acetabular labral tears are a potential source of hip pain in young adults. Many underlying conditions may predispose to labral degeneration and tear including prior trauma, femoroacetabular impingement (FAI), developmental dysplasia of the hip (DDH), capsular laxity, and congenital abnormalities involving the axis of the joint such as acetabular retroversion and anteversion. Labral tears rarely occur in the absence of bony abnormalities and that neglecting these underlying structural abnormalities may result in treatment failure. FAI is defined as an abnormal contact between the femoral head and the acetabulum that limits normal range of motion. Although two types were defined (pincer when focal or general acetabular over coverage occurs and cam when there is an abnormal contact between the femoral head-neck junction and the anterior acetabulum), most patients have mixed types.

Arthroscopy is the gold standard for clarifying diagnostic dilemmas but is an invasive procedure with possible complications and cannot be applied to every patient with suspected but not established hip pathology. Thus, imaging may play an important role in planning joint-preserving treatment options in those cases and thus preventing early hip osteoarthritis.

The diagnosis of a labral tear is made on CT arthrography (CTa) and MR arthrography (MRa) when contrast fluid gets inside the labrum. Fluid-sensitive sequences are needed on MRa to detect intrasubstance labrum changes, especially those that do not extend to the articular surface. Unless calcified, these changes are missed on CTa.

Much of the radiology literature has focused on the use of MRa of the hip to detect labral and cartilage pathology. Both non-contrast MRI and MRa have limitations in terms of spatial resolution, which can make the detection of subtle labral and cartilage pathology challenging.

CT arthrography (CTa) with its superior spatial resolution offers several advantages over plain MRI for the evaluation of articular cartilage. Image acquisition at a submillimeter scale together with the availability of multiplanar reformations can reveal early intraarticular changes that are poorly detected on plain MRI. Although Multidetector Computed Tomography (MDCT) has higher spatial resolution than MR, it has significantly lower contrast resolution, and thus labra and extraarticular pathology are not evaluated to the same extent.

CTa may be indicated in cases of MR incompatibility and MR contraindications. So in our study we try prospectively to evaluate the diagnostic value of CTa in comparison to MRa in detection of intraarticular hip pathology

Study Type

Observational

Enrollment (Anticipated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients of different sex and age groups presenting to the Radiology department with clinical and routine imaging suggestive of intraarticular hip pathology.

Description

Inclusion Criteria:

  • 60 consecutive patients presenting with clinical and routine imaging suggestive of intraarticular hip pathology.
  • patients must be accept the intraarticular hip injection of contrast.

Exclusion Criteria:

  • Any general contraindication of MRI in some cases as presence of anti-paramagnetic substance as pacemakers aneurysm clips, metallic cochlear implants
  • Severely ill patients or those with claustrophobia
  • Any general contraindications to radiation in some cases such as pregnancy at first trimester.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sensitivity
Time Frame: 1 week
Sensitivity refers to true positive rate, the percentage of patients with actual illness who was correctly diagnosed in overall patients by each of CT arthrography and MRI arthrography. High sensitivity indicated high correct rate in diagnosis of intra-articular hip pathology.
1 week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Specificity
Time Frame: 1 week
Specificity refers to true negative rate, the percentage of patients with actual disease-free who are correctly judged as disease-free according to the diagnostic criteria. The high specificity indicates high accuracy of diagnosis.
1 week
positive predictive value
Time Frame: 1 week
Positive predictive value refers to the proportion of patients with actual illness among all positive cases, can reflect the possibility of affecting target disease in patients with positive screening test result.
1 week
Negative predictive value
Time Frame: 1 week
Negative predictive value refers to the proportion of patients with negative screening test result who do not suffer from diseases.
1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Ehab Mohammad, A. Professor, Diagnostic radiology department Assiut university hospital
  • Study Director: Noha Attia, Lecturer, Diagnostic radiology department Assiut university hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

October 1, 2021

Primary Completion (ANTICIPATED)

October 1, 2022

Study Completion (ANTICIPATED)

December 1, 2022

Study Registration Dates

First Submitted

April 24, 2021

First Submitted That Met QC Criteria

April 24, 2021

First Posted (ACTUAL)

April 28, 2021

Study Record Updates

Last Update Posted (ACTUAL)

September 27, 2021

Last Update Submitted That Met QC Criteria

September 20, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • CTA vs MRA in hip pathology

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Disease

Clinical Trials on combined CT and MRI

Subscribe